DeNovX an innovative pharmaceutical company that provides platform products for pharmaceutical and medical nutrition uses. Our pharmaceutical products division is advancing the development of a treatment for ulcerative colitis. Our pharmaceutical technology division is focused on the commercialization of products to accelerate pharmaceutical development while creating new intellectual property (IP) for commercially relevant products.
View Top Employees from DeNovX| Website | http://www.denovx.com |
| Revenue | $405000 |
| Employees | 5 (5 on RocketReach) |
| Founded | 2011 |
| Address | 3440 S. Dearborn Street Suite 204 S, Chicago, Illinois 60616, US |
| Phone | (910) 333-6689 |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceuticals, Manufacturing, Research & Development, Crystal Engineering, Chemistry |
| Competitors | Amedio CMC Consulting LLC, Drug Discovery Alliances, Inc., LAXAI, Renovo Research, Velesco Pharmaceutical Services |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular DeNovX employee's phone or email?
DeNovX Questions
The DeNovX annual revenue was $405000 in 2024.
Andrew Bond is the Co-Founder and Chief Operations Officer of DeNovX.
5 people are employed at DeNovX.
DeNovX is based in Chicago, Illinois.
The NAICS codes for DeNovX are [325, 3254, 32541, 32].
The SIC codes for DeNovX are [283, 28].
Top DeNovX Employees
-
21
-
1
-
3
-
11
-
1
Related Companies
